Raveendra Pai

Title: Raveendra Pai: Innovator in Pressurized Inhalation Composition

Introduction

Raveendra Pai is a notable inventor based in Navi Mumbai, India. He has made significant contributions to the field of pharmaceutical compositions, particularly in the development of inhalation therapies. His innovative work focuses on improving the delivery of medication for respiratory conditions.

Latest Patents

Raveendra Pai holds a patent for a pressurized inhalation composition that includes tiotropium or its pharmaceutically acceptable salt, ethanol, a stabilizer, and a propellant. The composition is designed to be pharmacokinetically bioequivalent to non-pressurized aqueous base inhalation formulations of tiotropium. The ethanol content ranges from about 1% (w/w) to about 10% (w/w) based on the total weight of the composition. This invention aims to enhance the treatment of asthma and chronic obstructive pulmonary disease (COPD) through effective inhalation administration.

Career Highlights

Raveendra Pai is currently associated with Glenmark Specialty S.A., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing inhalation therapies that improve patient outcomes.

Collaborations

Raveendra has collaborated with notable colleagues such as Ramakant Chanagare and Jitendra Patil, contributing to the development of innovative solutions in respiratory treatments.

Conclusion

Raveendra Pai's contributions to the field of inhalation therapies exemplify the impact of innovation in medicine. His patent for a pressurized inhalation composition represents a significant advancement in the treatment of respiratory diseases.